SRTA · NASDAQ
Strata Critical Medical (SRTA) Stock Price & Fundamentals
Strata Critical Medical (SRTA) closed at $905.08 on Oct 9, 2026, up 1.17% from the previous close of $894.64.
Share price, past year
1Y +17.01%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $905.08 |
| Sep 30, 2026 | $859.52 |
| Aug 31, 2026 | $839.64 |
| Jul 31, 2026 | $842.53 |
| Jun 30, 2026 | $859.65 |
| May 29, 2026 | $829.77 |
| Apr 30, 2026 | $812.43 |
| Mar 31, 2026 | $811.61 |
| Feb 27, 2026 | $789.71 |
| Jan 30, 2026 | $763.22 |
| Dec 31, 2025 | $790.05 |
| Nov 28, 2025 | $783.86 |
| Oct 31, 2025 | $762.56 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $255.98M
- Net income (TTM)
- $40.22M
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $757.62 – $905.08
Financials
Strata Critical Medical reported revenue of $197.14M for fiscal 2025, up 34.28% from fiscal 2024.
Strata Critical Medical earned net income of $41.35M in fiscal 2025, a net margin of 21.0%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $197.14M | +34.3% | $41.35M | 21.0% | $0.50 | −$58.51M |
| FY2024ended Dec 31, 2024 | $146.82M | −34.8% | −$27.31M | −18.6% | −$0.35 | −$33.38M |
| FY2023ended Dec 31, 2023 | $225.18M | +54.1% | −$56.08M | −24.9% | −$0.76 | −$34.46M |
| FY2022ended Dec 31, 2022 | $146.12M | +189.2% | −$27.26M | −18.7% | −$0.38 | −$37.86M |
| FY2021ended Sep 30, 2021 | $50.53M | +115.6% | −$40.05M | −79.3% | −$0.93 | −$15.91M |
| FY2020ended Sep 30, 2020 | $23.43M | −24.9% | −$20.52M | −87.6% | −$0.40 | −$1.17M |
| FY2019ended Sep 30, 2019 | $31.20M | — | $2.33M | 7.5% | −$0.43 | −$10.91M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $72.51M | −$10.52M | −$0.12 |
| Q1 FY2026ended Mar 31, 2026 | $67.38M | $2.15M | $0.03 |
| Q4 FY2025ended Dec 31, 2025 | $66.79M | −$8.83M | — |
| Q3 FY2025ended Sep 30, 2025 | $49.30M | $57.42M | $0.70 |
| Q2 FY2025ended Jun 30, 2025 | $45.11M | −$3.74M | −$0.05 |
| Q1 FY2025ended Mar 31, 2025 | $35.95M | −$3.49M | −$0.04 |
| Q4 FY2024ended Dec 31, 2024 | −$8.70M | −$9.79M | — |
| Q3 FY2024ended Sep 30, 2024 | $36.06M | −$1.95M | −$0.03 |
Company profile
- Name
- Strata Critical Medical, Inc.
- Ticker
- SRTA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Health Services
- Headquarters
- 666 Third Avenue, 25th Floor, New York, NY 10017
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001779128
Recent SEC filings
- Aug 4, 2026
- Aug 4, 2026
- Jun 3, 2026
- May 6, 2026
- May 6, 2026
- Mar 3, 2026
- Mar 3, 2026
- Feb 5, 2026
Frequently asked questions
What is Strata Critical Medical's stock price?
Strata Critical Medical (SRTA) closed at $905.08 on Oct 9, 2026, up 1.17% from the previous close of $894.64.
How much revenue does Strata Critical Medical make?
Strata Critical Medical reported revenue of $197.14M for fiscal 2025, up 34.28% from fiscal 2024.
Does Strata Critical Medical pay a dividend?
Strata Critical Medical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Strata Critical Medical, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures